KRAS-Mutated Metastatic CRC
Case: A 38-year Old Woman WithKRAS-Mutated mCRC
Initial presentation
Clinical workup
Treatment
Peritoneal RFS May Be a Stronger Predictor of OS in CRC Peritoneal Metastasis
March 27th 2024In an interview with Targeted Oncology, Muhammad Talha Waheed, MBBS, discussed research on the reliability of using recurrence-free survival as an efficacy end point for trials evaluating patients with colorectal cancer peritoneal metastasis.
Read More